A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial | Zendy

Susie Jacob | Zendy; Christopher Brewer | Zendy; T. Tang | Zendy; HM Picton | Zendy; Julian H. Barth | Zendy; Adam Balen | Zendy

Open Access

A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial

Author(s) -

Susie Jacob,

Christopher Brewer,

T. Tang,

HM Picton,

Julian H. Barth,

Adam Balen

Publication year - 2016

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dew268

Subject(s) - ovarian hyperstimulation syndrome , metformin , medicine , polycystic ovary , placebo , gonadotropin releasing hormone antagonist , randomized controlled trial , hormone antagonist , gynecology , in vitro fertilisation , gonadotropin releasing hormone , antagonist , pregnancy , hormone , obesity , insulin resistance , insulin , biology , genetics , alternative medicine , pathology , luteinizing hormone , receptor

Does 'metformin' reduce the incidence of ovarian hyperstimulation syndrome (OHSS) for women with polycystic ovary syndrome (PCOS) undergoing a GnRH antagonist assisted conception treatment cycle?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research